Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney f...
Tuesday, May 28, 2024 6:31 PM
Obesity increases the likelihood of having mental illnesses considerably. Read further on Dynamite News:
Wednesday, May 31, 2023 6:23 PM
Eating a lot of fat raises the risk of metabolic disorders, but the mechanisms involved in the problem are not well understood. Read further on Dynami...
Tuesday, April 11, 2023 5:52 PM
Loading Poll …
Dynamite News